Source: Annual Congress 2013 –What's new in thoracic surgery: highlights for the pulmonologist



Rating:

Share or cite this content

Citations should be made in the following way:
M. Strueber (Leipzig, Germany). PAH: what surgeons can offer when medication fails. Annual Congress 2013 –What's new in thoracic surgery: highlights for the pulmonologist

Member's Comments

No comment yet.

Related content which might interest you: “I don’t think there’s a simple way of doing it:” the use of an electronic alert to identify excessive prescribing of short-acting beta2-agonists for people with asthma – a qualitative study with asthma experts and primary care staff Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care Year: 2020 Do general practitioners use effective communication for discussing patients‘ adherence with asthma medications? Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 What do we need in the clinic and what approach can clinicians take to improve the drug development pipeline? Source: ERS Research Seminar 2016 Year: 2016 Getting approval for new therapeutic medical devices versus drugs: are the differences justified? Source: Eur Respir Rev 2016; 25: 223-226 Year: 2016 Who should receive which biologic and why? Current and future approaches in severe asthma patients Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what? Year: 2021 What the pulmonary specialist should know about the new inhalation therapies Source: Eur Respir J 2012; 39: 1054-1055 Year: 2012 What the pulmonary specialist should know about the new inhalation therapies Source: Eur Respir J 2012; 39: 1055-1056 Year: 2012 What the pulmonary specialist should know about the new inhalation therapies Source: Guideline 2011 Year: 2011 Introducing a new formulation of pirfenidone to reduce tablet burden for the IPF patient: Is it tolerable? Is it easy to take? What do our patients think? Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 Implementing venous thromboprophylaxis in medical patients: an opt out approach Source: Annual Congress 2009 - Pulmonary embolism Year: 2009 The sustainability agenda and inhaled therapy: what do patients want? Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021 Which therapeutic options when CPAP fails?  Source: ERS Course 2017 - Paediatric noninvasive ventilation Year: 2017 Protocol of early mobilization and rehabilitation in critical patients using inotropic medications: Is it really safe? Our hands on practice! Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases Year: 2019 COPD guides and inhaled corticosteroids. Is there an adequate use in primary care? Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 Which are the best methods to manage COPD patients in the post-COVID era? Source: Virtual Congress 2021 – Part I: restarting COPD care in the post-COVID era Year: 2021 A survey of specialist opinions on biomarker use in severe asthma in Australia: scepticism but hope? Source: ERJ Open Res, 6 (2) 00113-2020; 10.1183/23120541.00113-2020 Year: 2020 Clinical impact of a program to educate community pharmacists in providing proper inhalation technique for asthma patients Source: Annual Congress 2011 - Medical education Year: 2011 The need for a specialist multidisciplinary clinic to manage paediatric patients with severe asthma in the age of biologics Source: International Congress 2019 – PG11 Severe paediatric asthma Year: 2019 The issues and the controversies: are we really ready for on-demand use of ICS? Source: Annual Congress 2013 –Inhaled corticosteroids for asthma: on-demand or continuous use? Year: 2013